Patent Law Weblog
recent posts
- Quo Vadis mRNA Vaccine Technology? The State of the IP Lawsuits
- Moderna Settles Patent Litigation with Arbutus et al.
- USPTO and DOJ Statement of Interest in Collision Communications: Another Thumb on the Scale in Favor of NPE Patent Plaintiffs
- Oasis Tooling, Inc. v. Siemens Industry Software Inc. (Fed. Cir. 2026)
- Why AI Will Not Take Over the World
about
Category: International IP
-
By Donald Zuhn — Earlier this month, the World Intellectual Property Organization (WIPO) released a report on intellectual property trends in 2008 and 2009 showing that innovative activity and demand for IP rights dipped during the global economic crisis, but began to recover this year. Commenting on the report, WIPO Director General Francis Gurry stated…
-
By Donald Zuhn — Last week, the World Intellectual Property Organization (WIPO) announced the launch of WIPO Lex, a new online global IP resource providing up-to-date information on national IP laws and treaties. WIPO noted that the new site satisfied one of the Organization's strategic goals, namely to serve as a world reference source for…
-
By Donald Zuhn — USPTO and ROSPATENT Begin Patent Prosecution Highway Pilot Program On Monday, the U.S. Patent and Trademark Office announced that it had agreed to partner with the Federal Service for Intellectual Property, Patents and Trademarks of the Russian Federation (ROSPATENT) in establishing a Patent Prosecution Highway (PPH) pilot program. As with other…
-
By Alejandro Luna — On Friday, August 13, 2010, the Mexican Trademark and Patent Office (IMPI) made available through its website the new edition of the Linkage Gazette (Mexican health and IP law regulations require IMPI to publish a gazette every six months listing patents in force that cover allopathic drugs). Regrettably, IMPI decided to…
-
By Juan Serrano — Following up on the note for future regulations to approve biotechnological drugs in Mexico (see "Mexico to Issue Regulations for Approval of 'Biocomparable' Drugs"), documents with comments have been uploaded to the official website of the Federal Commission for Regulatory Improvement (COFEMER). The first of these documents is an official communication…
-
By Ignacio Sanchez Echagüe — The Argentine Patent Office (Instituto Nacional de la Propiedad Industrial, INPI) has issued Regulation No. 147/2010, which restricts the ability of applicants to file divisional applications once substantive examination has begun. The regulation, which went into effect on July 16, 2010, allows applicants to file divisional applications until notice…
-
By Juan Serrano — The Mexican General Health Law was reformed on June 11, 2009 to include an article 222 bis, which defined biotechnological drugs, and allowed for the approval of "biocomparables." The decree came into force on September 8, 2009, and the Ministry of Health had a 180-day period to issue all specific…
-
By James DeGiulio — Earlier this year, we reported that the European Competitiveness Council unanimously adopted a legislative package designed to create a single EU Patent and EU Patent court (see "Europe Takes Step Closer to Single EU Patent and Patent Court"). However, as noted, EU Patent translations remained a sticking point in the…
-
By Devanand Crease — The much anticipated ruling in Monsanto Technology v Cefetra (Case C-428/08) has now issued and confirms the earlier indications that within the European Union (EU) patent protection for gene sequences only extends to material in which the patented gene is actually performing its function. In Monsanto's case (European Patent No.…
-
By Juan Serrano — On June 18, 2010, a decree was published in the Federal Official Gazette, reforming several provisions of the Mexican IP law related to patent practice. The main amendments are the following: a) The industrial application requirement for patentability was modified to include a need to demonstrate the possibility of "practical utility"…
Patent Docs 